Risk Factors That Affect the Surgical Outcome in the Management of Focal Bronchiectasis in a Developed Country

Surgical treatment of bronchiectasis: A retrospective observational study of 260 patients

“…Miyako Hiramatsu et al showed that an immunocompromised status, P. aeruginosa infection, and the extent of residual bronchiectasis were significantly related with the shorter relapse-free interval by univariate analysis [8]. Age was one of the factors that affected the complications after operation, which was consistent with the previous result [13].…”

“…But bronchiectasis is still an important problem for some serious pulmonary infections in developing countries [7]. Conservative treatments, such as antibiotic treatment, postural drainage and bronchodilators, have been used to control the symptom, but a mortality of 19e31% still exists [8]. In addition, surgical resection can alleviate symptoms or shorten the duration of conservative treatment, which has been applied in the bronchiectasis treatment from the late 1930s [9].…”

British Thoracic Society Guideline for bronchiectasis in adults

“…223 225 232 239 240 In one small case series of 31 patients, the mean time to recurrence of symptoms was 34 months. 232 An immunocompromised status, persistent infection with P. aeruginosa and the extent of residual bronchiectasis after surgery have been associated with a significantly shorter recurrence-free interval. 232 The primary cause of bronchiectasis may influence post-surgical outcomes with likely better outcomes after post obstructive bronchiectasis and poorer outcomes in immunodeficiency.…”

“…232 An immunocompromised status, persistent infection with P. aeruginosa and the extent of residual bronchiectasis after surgery have been associated with a significantly shorter recurrence-free interval. 232 The primary cause of bronchiectasis may influence post-surgical outcomes with likely better outcomes after post obstructive bronchiectasis and poorer outcomes in immunodeficiency. 232 There are however limited data to guide clinicians in defining risk benefit ratios.…”

“…232 The primary cause of bronchiectasis may influence post-surgical outcomes with likely better outcomes after post obstructive bronchiectasis and poorer outcomes in immunodeficiency. 232 There are however limited data to guide clinicians in defining risk benefit ratios. 229 238 Even when the primary cause of bronchiectasis persists, successful outcomes are reported.…”